These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14612353)

  • 1. Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients.
    Sermet-Gaudelus I; Souberbielle JC; Azhar I; Ruiz JC; Magnine P; Colomb V; Le Bihan C; Folio D; Lenoir G
    Arch Dis Child; 2003 Nov; 88(11):956-61. PubMed ID: 14612353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis.
    Taylor AM; Bush A; Thomson A; Oades PJ; Marchant JL; Bruce-Morgan C; Holly J; Ahmed L; Dunger DB
    Arch Dis Child; 1997 Apr; 76(4):304-9. PubMed ID: 9166020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1, leptin, body composition, and clinical status interactions in children with cystic fibrosis.
    Boguszewski MC; Kamoi TO; Bento Radominski R; Boguszewski CL; Rosberg S; Filho NA; Sandrini Neto R; Albertsson-Wikland K
    Horm Res; 2007; 67(5):250-6. PubMed ID: 17215581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between serum Insulin-like growth factor-I and insulin-like growth factor-binding protein-3 levels, clinical status and growth parameters in prepubertal cystic fibrosis patients.
    Ozen M; Cokugras H; Ozen N; Camcioglu Y; Akcakaya N
    Pediatr Int; 2004 Aug; 46(4):429-35. PubMed ID: 15310308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulinlike growth factor-1 treatment in children with cystic fibrosis.
    Bucuvalas JC; Chernausek SD; Alfaro MP; Krug SK; Ritschel W; Wilmott RW
    J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):576-81. PubMed ID: 11740232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between insulin, IGF-I and weight gain in cystic fibrosis.
    Taylor AM; Thomson A; Bruce-Morgan C; Ahmed ML; Watts A; Harris D; Holly JM; Dunger DB
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):659-65. PubMed ID: 10594529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin and IGF-I levels in cystic fibrosis.
    Arumugam R; LeBlanc A; Seilheimer DK; Hardin DS
    Endocr Res; 1998 May; 24(2):247-57. PubMed ID: 9738701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between body composition and pulmonary function in children and young people with cystic fibrosis.
    Calella P; Valerio G; Thomas M; McCabe H; Taylor J; Brodlie M; Siervo M
    Nutrition; 2018 Apr; 48():73-76. PubMed ID: 29469024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of association between lean body mass and serum insulin-like growth factor-1 in continuous ambulatory peritoneal dialysis patients].
    Numata M; Yamamoto H; Kawaguchi Y; Osaka N; Nakayama M; Kubo H; Shigematsu T; Hosoya T
    Nihon Jinzo Gakkai Shi; 1999 Jan; 41(1):8-13. PubMed ID: 10077982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor.
    Engvall IL; Elkan AC; Tengstrand B; Cederholm T; Brismar K; Hafstrom I
    Scand J Rheumatol; 2008; 37(5):321-8. PubMed ID: 18666027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in cystic fibrosis: a positive effect of antibiotic therapy and hyperalimentation.
    Lebl J; Zahradníková M; Bartosová J; Zemková D; Pechová M; Vávrová V
    Acta Paediatr; 2001 Aug; 90(8):868-72. PubMed ID: 11529532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of nutritional status in children with cystic fibrosis: conventional anthropometry and bioelectrical impedance analysis. A cross-sectional study in Dutch patients.
    Groeneweg M; Tan S; Boot AM; de Jongste JC; Bouquet J; Sinaasappel M
    J Cyst Fibros; 2002 Dec; 1(4):276-80. PubMed ID: 15463827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of body mass index percentile to identify fat-free mass depletion in children with cystic fibrosis.
    Engelen MP; Schroder R; Van der Hoorn K; Deutz NE; Com G
    Clin Nutr; 2012 Dec; 31(6):927-33. PubMed ID: 22607714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition analysis by dual-energy x-ray absorptiometry in adults with cystic fibrosis.
    Rochat T; Slosman DO; Pichard C; Belli DC
    Chest; 1994 Sep; 106(3):800-5. PubMed ID: 8082362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Pseudomonas colonization on body composition and resting energy expenditure in children with cystic fibrosis.
    Vinton NE; Padman R; Davis M; Harcke HT
    JPEN J Parenter Enteral Nutr; 1999; 23(4):233-6. PubMed ID: 10421394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
    Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
    Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of anticancer treatment on leptin level, fat body mass (FM) and lean body mass (LBM)].
    Krawczyk-Rybak M; Muszyńska-Rosłan K; Konstantynowicz J; Solarz E; Wołczynski S; Protas P
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):297-307. PubMed ID: 15738606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease in lean body mass in men with prostate cancer receiving androgen deprivation therapy: mechanism and biomarkers.
    Hara N; Ishizaki F; Saito T; Nishiyama T; Kawasaki T; Takahashi K
    Urology; 2013 Feb; 81(2):376-80. PubMed ID: 23374809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.